Document Detail


Iodine repletion, thyrotoxicosis and atrial fibrillation in Isfahan, Iran.
MedLine Citation:
PMID:  15310007     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Iodized salt was reintroduced in Iran in 1989. Just before distribution of iodized salt, thyrotoxicosis was observed in 3.7% of the patients with atrial fibrillation (AF) in university teaching hospitals in Isfahan, a centrally located city in Iran. As repletion of iodine may increase the rate of autoimmune thyroid diseases and toxic multinodular goiter, this study was designed to evaluate the rate of thyrotoxicosis in patients with AF in the same hospitals after about a decade of iodized salt consumption. METHODS: In a case-control study with convenience sampling, 100 patients with AF and an equal number of age- and sex-matched subjects taking the same medications were selected as case and control groups, respectively, in university hospitals in 1997. RESULTS: Eight percent of patients with atrial fibrillation had overt thyrotoxicosis versus one percent in the control group (odds ratio=8.6, 95% CI = 6.5 to 10.7, P<0.02). Thyrotoxicosis in patients with AF was 8 times higher than in the control group without AF. In comparison with the period before use of iodized salt, AF more than doubled (8% vs. 3.7%). CONCLUSION: Thyroid function should be evaluated in all patients older than 40 years of age with AF. The benefits of iodine supplementation are great, but more attention should be paid to the complications of iodine repletion, including thyrotoxicosis and its frequent accompaniment, AF.
Authors:
Ashraf Aminorroaya; Sina Rohani; Goshtasb Sattari; Sasan Haghighi; Masoud Amini
Related Documents :
17702897 - Effect of the complement inhibitor eculizumab on thromboembolism in patients with parox...
16923757 - Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with...
17315377 - Left atrial volume: predictor of atrial fibrillation in patients with degenerative mitr...
18186567 - Referral for anorectal function evaluation is indicated in 65% and beneficial in 92% of...
18223497 - Use of ph-impedance testing to evaluate patients with suspected extraesophageal manifes...
17702897 - Effect of the complement inhibitor eculizumab on thromboembolism in patients with parox...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of Saudi medicine     Volume:  24     ISSN:  0256-4947     ISO Abbreviation:  Ann Saudi Med     Publication Date:    2004 Jan-Feb
Date Detail:
Created Date:  2004-08-16     Completed Date:  2004-11-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8507355     Medline TA:  Ann Saudi Med     Country:  Saudi Arabia    
Other Details:
Languages:  eng     Pagination:  13-7     Citation Subset:  IM    
Affiliation:
Isfahan Endocrine and Metabolism Research Center, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. aminorroaya@med.mui.ac.ir
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Distribution
Aged
Atrial Fibrillation / epidemiology*
Case-Control Studies
Comorbidity
Female
Humans
Hyperthyroidism / epidemiology
Hypothyroidism / epidemiology
Incidence
Iodine / deficiency,  therapeutic use*
Iran / epidemiology
Male
Middle Aged
Sodium Chloride, Dietary / therapeutic use*
Thyrotoxicosis / drug therapy,  epidemiology*,  prevention & control*
Chemical
Reg. No./Substance:
0/Sodium Chloride, Dietary; 0/iodized salt; 7553-56-2/Iodine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum leptin and body composition in polycystic ovarian syndrome.
Next Document:  Partially purified fraction (PPF) antigen from adult Fasciola gigantica for the serodiagnosis of hum...